These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9864812)

  • 1. [Isoptin. Evolution of views from Fleckenstein to the present days].
    Makolkin VI; Podzolkov VI
    Ter Arkh; 1998; 70(10):79-81. PubMed ID: 9864812
    [No Abstract]   [Full Text] [Related]  

  • 2. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trandolapril / verapamil SR combination reverses drug-induced new-onset diabetes.
    Cardiovasc J Afr; 2008; 19(2):118. PubMed ID: 18516363
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Change in inotropic and chronotropic function of the heart and resistance of the coronary vessels during combined use of Ca2+ antagonists].
    Tkachenko BI; Kostko SZ; Katsenovich RA; Stepanova TG; Shil'kurt BL
    Biull Eksp Biol Med; 1991 Jun; 111(6):584-6. PubMed ID: 1893174
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
    Basile J
    J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in cardiological practice].
    Ol'binskaia LI
    Kardiologiia; 1990 Dec; 30(12):100-3. PubMed ID: 2097383
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams?
    Glassock RJ
    J Am Soc Nephrol; 2006 Dec; 17(12):3276-8. PubMed ID: 17108313
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
    Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
    Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in the treatment of hypertension: a critical overview.
    Weidmann P; Gerber A; Laederach K
    Adv Nephrol Necker Hosp; 1985; 14():197-232. PubMed ID: 3919532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selective action of calcium antagonists].
    Heinzl S
    Med Monatsschr Pharm; 1990 Mar; 13(3):66-8. PubMed ID: 2319983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative efficacy of and tolerance to prestarium and lomir in long-term treatment of hypertensive subjects].
    Nesterov IuI; Ivanova IV; Gol'dberg GA
    Klin Med (Mosk); 1998; 76(3):41-3. PubMed ID: 9575747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimization of the control of blood pressure. What contribution can be obtained from use of combinations of fixed doses of ace inhibitors and calcium channel blockers?].
    Eliseev OM
    Ter Arkh; 2011; 83(5):70-5. PubMed ID: 21780662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and regional haemodynamic effects of vasodilators in hypertension.
    Struyker-Boudier HA; Smits JF
    Neth J Med; 1984; 27(4):146-52. PubMed ID: 6330588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.